← European Medicine Shortage Tracker · all medicines

Xilometazolina cloridrato shortage — availability across Europe

Xilometazolina cloridrato currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: XILOMETAZOLINA CLORIDRATO · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Xilometazolina cloridrato, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2026-03-16 and has now been open for about 5 months. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 2 stated-cause reports, followed by manufacturing problems with 1. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
RINAADVANCE
+ 1 more products
XILOMETAZOLINA EG
2026-03-16Cessata commercializzazione definitiva
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2026-03: 12026-04: 12026-032026-04

Full report history (2 register entries)

Every individual register entry for Xilometazolina cloridrato in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITXILOMETAZOLINA EGShortage2026-04-01Problemi produttivi
🇮🇹 ITRINAADVANCEShortage2026-03-16Cessata commercializzazione definitiva

Frequently asked

Is Xilometazolina cloridrato currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Xilometazolina cloridrato?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Xilometazolina cloridrato availability data come from?

Directly from the official medicines-agency register that lists Xilometazolina cloridrato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Xilometazolina cloridrato — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/xilometazolina-cloridrato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Xilometazolina cloridrato availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/xilometazolina-cloridrato/">Xilometazolina cloridrato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Xilometazolina cloridrato: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.